908 Devices Inc. (MASS)
- Previous Close
5.56 - Open
5.77 - Bid 5.64 x 500
- Ask 5.69 x 500
- Day's Range
5.54 - 5.79 - 52 Week Range
4.85 - 12.51 - Volume
123,454 - Avg. Volume
163,269 - Market Cap (intraday)
186.599M - Beta (5Y Monthly) 0.93
- PE Ratio (TTM)
-- - EPS (TTM)
-1.13 - Earnings Date Apr 30, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
15.33
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
908devices.comRecent News: MASS
Performance Overview: MASS
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MASS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MASS
Valuation Measures
Market Cap
186.60M
Enterprise Value
46.86M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.64
Price/Book (mrq)
1.13
Enterprise Value/Revenue
0.93
Enterprise Value/EBITDA
-1.38
Financial Highlights
Profitability and Income Statement
Profit Margin
-72.47%
Return on Assets (ttm)
-11.99%
Return on Equity (ttm)
-20.44%
Revenue (ttm)
50.23M
Net Income Avi to Common (ttm)
-36.4M
Diluted EPS (ttm)
-1.13
Balance Sheet and Cash Flow
Total Cash (mrq)
145.68M
Total Debt/Equity (mrq)
3.59%
Levered Free Cash Flow (ttm)
-14.85M